The company primarily develops residential real estate projects in Maharashtra and Gujarat and has recently begun diversifying into solar energy services.
The company lacks a durable competitive advantage, as evidenced by negative average net margins and a return on capital employed that fails to exceed its cost of capital. The business operates in a highly fragmented, commodity-like segment of the real estate market with no discernible pricing power or cost edge.
Management has shifted capital from a struggling real estate business into a speculative solar venture while simultaneously issuing warrants and shares to non-promoters. The track record is poor, characterized by a significant destruction of per-share value and a lack of meaningful returns on reinvested capital.
The company's pivot from a failing real estate operation to a speculative solar venture proved to be a value-destroying distraction rather than a savior. By 2029, the capital injected into the solar business failed to generate returns above the cost of capital, while the core real estate assets continued to stagnate. The combination of negative cash conversion and persistent share dilution through preferential warrants effectively hollowed out the equity, leaving shareholders with a shell of a business that prioritized executive compensation and related-party loans over productive reinvestment.
RichFakir rates Jet Solar Ltd's business quality as poor — 15/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Jet Solar Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Jet Solar Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Jet Solar Ltd's fair value is about ₹0 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →